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Toward a Better Understanding of...

The Effect of KATP Channel Mutations
on Inhibitor Sensitivity:
Implications for Personalized Treatment
of Cantu Syndrome
David Tyus
Mentor: Conor McClenaghan
Cantu Syndrome (CS) is a rare, complex disease characterized by a wide array of
cardiovascular features caused by mutations resulting in the overactivity of ATP-sensitive
potassium (KATP) channels. KATP channels are heteromeric complexes composed of poreforming Kir6.x and regulatory SURx subunits. Currently, no cure exists for CS, but KATP
inhibitors are promising candidates for the treatment of the disease; however, the effect
of CS mutations on drug sensitivity have yet to be established. The goal of this project
was to test a range of inhibitors against KATP channel mutations found in CS patients
(Kir 6.1[V65M] and Kir 6.1[C176S]) to investigate their potential clinical benefit. KATP
activity in the presence or absence of inhibitors (glibenclamide, repaglinide [both SURx
interacting], and terfenadine [Kir6.x interacting]) was determined by measuring the
efflux of radioactive 86Rb+ from CosM6 cells transfected with wild type or mutated
channels. These results show that these mutations resulted in decreased sensitivity to
inhibitors of diverse structural classes which bind to different channel subunits. These
findings demonstrate the need for comprehensive studies to investigate the effects of
CS mutations on inhibitor sensitivity. Furthermore, these results predict poor clinical
outcomes of certain KATP inhibitors for CS patients, which highlights the requirement for
the development of novel inhibitors with new mechanisms of action.
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